Sen. Chuck Grassley (R-IA) with Sens. Marsha Blackburn (R-TN) and Ron Johnson (R-WI) (Graeme Sloan/Sipa USA/Sipa via AP Images)

Sen­a­tors call on NIH to take ac­tion on slow-to-re­port clin­i­cal tri­al spon­sors

With tens of bil­lions in an­nu­al ap­pro­pri­a­tions, a group of four Re­pub­li­can sen­a­tors is pub­licly won­der­ing why the Na­tion­al In­sti­tutes of Health can’t do a bet­ter job of en­sur­ing tax­pay­er-fund­ed re­search is pub­lished in a time­ly man­ner, they said in a let­ter sent last week to NIH act­ing di­rec­tor Lawrence Tabak.

The let­ter comes as a re­cent HHS in­spec­tor gen­er­al re­port found that 72 clin­i­cal tri­als re­quir­ing re­sults to be sub­mit­ted in 2019 or 2020 were sub­mit­ted on time, late or not sub­mit­ted at all. While NIH con­curred with the Au­gust re­port’s rec­om­men­da­tions and said it would take steps to ad­dress them, the sen­a­tors are cu­ri­ous as to what ex­act­ly NIH is do­ing on the mat­ter.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.